Novo Nordisk A-S

Novo Nordisk A-S

Yahoo Finance • 5 hours ago

Novo Nordisk (CPSE:NOVO B) Stock Faces Q3 Earnings Profit Squeeze

Novo Nordisk walked into this Q3 2026 release with a mixed recent run, the stock up about 10% over the past month but still down roughly 11% over three months. Today the headline is simple: solid top line, tighter profits. Revenue for the... Full story

Yahoo Finance • 8 hours ago

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Novo Nordisk A/S Bagsværd, Denmark. 5 November 2026 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance wit... Full story

Yahoo Finance • yesterday

Will Raised Outlook Change Novo Nordisk Stock Narrative

Novo Nordisk reported third quarter 2026 sales of DKK 79,195 million and net income of DKK 16,740 million, raised its full year sales and profit outlook, and cited strong demand for GLP 1 obesity and diabetes treatments, especially the Weg... Full story

Yahoo Finance • yesterday

Novo Nordisk AS (NVO) (Q3 2026) Earnings Call Highlights: Obesity Sales Surge 22% as Wegovy ...

This article first appeared on GuruFocus. Adjusted Sales: Increased 4% to DKK 79.2 billion in Q3 2026, driven by volume growth across U.S. and International Operations, primarily in obesity. Adjusted Operating Profit: Increased 27% in Q3... Full story

Yahoo Finance • yesterday

Novo Nordisk Stocks Rise 5.65% While Higher Guidance Meets Diverging Profit Measures

This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) gave investors a reason to buy Wednesday. The Danish drugmaker's U.S. depositary shares rose 5.65% to $42.46 at 10:35 a.m. ET on November 4 after it raised its annual outlo... Full story

Yahoo Finance • yesterday

Sector Update: Healthcare Stocks Rise Wednesday Afternoon

Healthcare stocks were higher Wednesday afternoon, with the NYSE Healthcare Index rising 2.6% and th Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news Full access to Financial Times and MT N... Full story

Yahoo Finance • yesterday

Novo Nordisk CEO says CVS breakup has no material impact on the weight-loss drug giant

For now, Novo Nordisk (NVO) CEO Mike Doustdar says it's business as usual for its weight-loss drug behemoth as healthcare giant CVS Health (CVS) undergoes a complicated breakup. "In some ways, I would say I don't see a material impact for... Full story

Yahoo Finance • yesterday

Wegovy CEO Reveals a Surprise in Weight-Loss Drug Race

This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) raised its 2026 outlook again Wednesday after stronger-than-expected third-quarter results, with the newly launched Wegovy pill emerging as the clearest bright spot in the... Full story

Yahoo Finance • yesterday

European Stocks Rally in Wednesday Trading Following US Elections; Euro Area Inflation Rises

The European stock markets surged in Wednesday trading following US elections that saw the Democrats Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news Full access to Financial Times and MT N... Full story

Yahoo Finance • yesterday

CNS Summit Announces Sanofi as No. 1 in the 2026 Digital Innovation Index

BOSTON, Nov. 4, 2026 /PRNewswire/ -- Sanofi ranked first in the 2026 CNS Summit Digital Innovation Index, developed in collaboration with IDEA Pharma, a division of SAI MedPartners, placing in the top three in all three categories. The ran... Full story

Yahoo Finance • yesterday

European Equities Traded in the US as American Depositary Receipts Advance Sharply in Wednesday Trading

European equities traded in the US as American depositary receipts were tracking significantly highe Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news Full access to Financial Times and MT N... Full story

Yahoo Finance • yesterday

Novo Surges 6% After Walloping Expectations On The Back Of Its GLP-1 Drugs

Novo stock popped early Wednesday on better-than-expected third-quarter sales and profit thanks to resounding beats from its GLP-1 drugs. Continue Reading... Full story

Yahoo Finance • yesterday

Wegovy pill launch 'exceeded our expectations': Novo Nordisk CEO

Novo Nordisk (NVO) CEO and president Mike Doustdar sits down Yahoo Finance Executive Editor Brian Sozzi to discuss the success that the pharmaceutical giant has seen in launching its Wegovy GLP-1 weight-loss pill. Video Transcript 00:00... Full story

Yahoo Finance • yesterday

Novo Nordisk (CPSE:NOVO B) Raised Its Outlook, Is The Stock Still Undervalued?

Novo Nordisk (CPSE:NOVO B) just reported third quarter 2026 earnings, giving investors fresh numbers on sales, profit and earnings per share after a mixed year for the stock. Recent trading has been choppy for Novo Nordisk, with the share... Full story

Yahoo Finance • yesterday

Post-election gridlock might be a bullish sign for Apple,

Yahoo Finance Executive Editor Brian Sozzi explains why he views any post-midterm election moves in the AI space as a bullish signal for Apple (AAPL). Plus, who are the winners and losers from the changes in Congress? Sozzi sits down with... Full story

Yahoo Finance • yesterday

Novo Nordisk Stock Shrugs Off Eli Lilly Threat as Weight-Loss Pill Shines in Earnings

The Danish drugmaker has had a dismal year, but its third-quarter earnings on Wednesday finally gave the market a reason to feel hopeful. Continue Reading... Full story

Yahoo Finance • yesterday

Novo Nordisk CEO: Wegovy pill 'exceeded our expectations'

The Wegovy pill looks like a win for Novo Nordisk (NVO) after what some on Wall Street saw as a slower-than-expected consumer uptake. "The Wegovy pill has exceeded our expectations," Novo Nordisk CEO Mike Doustdar said on Sozzi Unleashed.... Full story

Yahoo Finance • yesterday

Novo Surges 5% After Walloping Expectations On The Back Of Its GLP-1 Drugs

Novo stock popped early Wednesday on better-than-expected third-quarter sales and profit thanks to resounding beats from its GLP-1 drugs. Continue Reading... Full story

Yahoo Finance • yesterday

Stocks making the biggest moves premarket: Trump Media, Tesla, CoreWeave, Novo Nordisk and more

Check out the companies making the biggest moves in premarket trading: Trump Media & Technology Group — Shares of President Donald Trump 's social media company and tech company were down 11% after a decisive victory by Democrats in the U.... Full story

Yahoo Finance • yesterday

Novo Nordisk Weight-Loss Pill Sales Soar. One Other Earnings Revelation Boosting the Stock.

The Danish drugmaker has had a dismal year, but its third-quarter earnings on Wednesday finally gave the market a reason to feel hopeful. Continue Reading... Full story